The contribution of spinal card neurokinin-1 receptor signaling to pain

被引:13
|
作者
Trafton, JA
Basbaum, AI
机构
[1] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Physiol, Neurosci Program, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA
来源
JOURNAL OF PAIN | 2000年 / 1卷 / 03期
关键词
tachykinin; substance P; neurokinin A; inflammation; primary afferent; nociception; parabrachial;
D O I
10.1054/jpai.2000.9806
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Discovery of the occurrence of neurokinin-1 (NK-1) receptor internalization in response to agonist activation has provided researchers with a new tool for studying tachykinin actions. Using the readily observable end point of NK-1 receptor internalization as an activity marker, this observation has allowed for more detailed study of tachykinin systems in vivo and in vitro. What has this technique taught us about tachykinin function and activity in the spinal cord? Here we discuss recent findings, which shed light on the functional relevance of receptor internalization, the regulation of neuropeptide release from primary afferent nociceptors, and the signaling produced by tachykinins during nociception and injury. The potential consequences of these discoveries for the treatment of pain and understanding of the role of tachykinins in nociception are discussed.
引用
收藏
页码:57 / 65
页数:9
相关论文
共 50 条
  • [31] The neurokinin-1 receptor is expressed with gastrin-releasing peptide receptor in spinal interneurons and modulates itch
    Sheahan, Tayler
    Warwick, Charles
    Fanien, Louis
    Ross, Sarah
    JOURNAL OF PAIN, 2021, 22 (05): : 578 - 578
  • [32] Signaling via neurokinin-1 receptor is required for cellular immunity induced by melanoma vaccines
    Larregina, Adriana
    Mathers, Alicia
    Tkacheva, Olga
    Morelli, Adrian
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [33] Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain
    Jarcho, Johanna M.
    Feier, Natasha A.
    Bert, Alberto
    Labus, Jennifer A.
    Lee, Maunoo
    Stains, Jean
    Ebrat, Bahar
    Groman, Stephanie M.
    Tillisch, Kirsten
    Brody, Arthur L.
    London, Edythe D.
    Mandelkern, Mark A.
    Mayer, Emeran A.
    PAIN, 2013, 154 (07) : 987 - 996
  • [34] Neurokinin-1 receptor-based bivalent drugs in pain management: The journey to nowhere?
    Kleczkowska, Patrycja
    Nowicka, Katarzyna
    Bujalska-Zadrozny, Magdalena
    Hermans, Emmanuel
    PHARMACOLOGY & THERAPEUTICS, 2019, 196 : 44 - 58
  • [35] Neurokinin-1 receptor gene expression in the mouse dorsal horn increases with neuropathic pain
    Taylor, BK
    McCarson, KE
    JOURNAL OF PAIN, 2004, 5 (02): : 71 - 76
  • [36] Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists
    Molinos-Quintana, A.
    Trujillo-Hacha, P.
    Piruat, J. I.
    Bejarano-Garcia, J. A.
    Garcia-Guerrero, E.
    Perez-Simon, J. A.
    Munoz, Miguel
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (01) : 17 - 26
  • [37] Regulation of neurokinin-1 receptor expression by GABAB receptor agonists
    Enna, SJ
    Harstad, EB
    McCarson, KE
    LIFE SCIENCES, 1998, 62 (17-18) : 1525 - 1530
  • [38] Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists
    A. Molinos-Quintana
    P. Trujillo-Hacha
    J. I. Piruat
    J. A. Bejarano-García
    E. García-Guerrero
    J. A. Pérez-Simón
    Miguel Muñoz
    Investigational New Drugs, 2019, 37 : 17 - 26
  • [39] A SELECTIVE AND EXTREMELY POTENT ANTAGONIST OF THE NEUROKININ-1 RECEPTOR
    SAKURADA, T
    MANOME, Y
    TANNO, K
    SAKURADA, S
    OHBA, M
    KISARA, K
    TERENIUS, L
    REGULATORY PEPTIDES, 1993, 46 (1-2) : 326 - 328
  • [40] Substance P and neurokinin-1 receptor modulation of HIV
    Ho, WZ
    Douglas, SD
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 157 (1-2) : 48 - 55